scholarly journals The effects of an empowering self-management model on self-efficacy and sense of coherence among retired elderly with chronic diseases: a randomized controlled trial

2018 ◽  
Vol Volume 13 ◽  
pp. 2215-2224 ◽  
Author(s):  
Azam Hourzad ◽  
Shahnaz Pouladi ◽  
Afshin Ostovar ◽  
Maryam Ravanipour
Keyword(s):  
Randomized Controlled Trial ◽  
Chronic Diseases ◽  
Sense Of Coherence ◽  
Self Efficacy ◽  
Controlled Trial ◽  
Management Model ◽  
Self Management ◽  
Randomized Controlled

scholarly journals Video consultation as an adequate alternative to face-to-face consultations in CPAP use for patients with obstructive sleep apnea: a Randomized Controlled Trial. (Preprint)

2020 ◽  
Author(s):  
L. Kooij ◽  
P. J. E. Vos ◽  
A. Dijkstra ◽  
E. A. Roovers ◽  
W. H. van Harten
Keyword(s):  
Randomized Controlled Trial ◽  
Self Efficacy ◽  
Controlled Trial ◽  
Outcome Expectancies ◽  
Self Management ◽  
Face To Face ◽  
Randomized Controlled ◽  
Cognitive Components ◽  
Video Consultation ◽  
Over Time

BACKGROUND The effectiveness of Continuous Positive Airway Pressure (CPAP) is dependent on the degree of use, so adherence is essential. Cognitive components (e.g. self-efficacy) are found to be important in predicting CPAP use. Telemedicine interventions are increasingly used to support self-management in different chronic diseases. Especially video consultation is a promising way of supporting OSA patients, and may be beneficial during treatment. So far video consultation is seldom evaluated through thorough controlled research, with only a limited number of outcomes assessed. OBJECTIVE To evaluate the effects of video consultation versus face-to-face consultation for patients with OSA on patients’ CPAP use (minutes/per night), self-efficacy, risk outcomes, outcome expectancies, experiences with technology and, patients’ and professionals’ satisfaction. METHODS A Randomized Controlled Trial was conducted with an intervention- (video consultations) and a usual care group (face-to-face consultations) with CPAP use assessments after 4, 12 and 24 weeks. Patients with confirmed OSA (AHI > 15), requiring CPAP treatment, no history of CPAP treatment, having access to a tablet/smartphone and proficiency of the Dutch language were included in the study. Patients completed questionnaires at baseline and after one month on self-efficacy, risk perception, outcome expectancies (using Self-Efficacy Measure for Sleep Apnea), expectations and experiences with video consultations (covering constructs of the Unified Theory of Acceptance and Use of Technology) and satisfaction. RESULTS In both groups CPAP use decreased over time (P=.01) similarly. No significant difference in change over time (week 4, 12 and 24) between groups was found for CPAP use (P interaction term P=.54). Self-efficacy appeared to have a statistically significant effect on CPAP use in both groups (P=.001), regardless of the intervention arm (P=.27). Patients in both groups were satisfied with the consultations and rated these respectively with an 8.4 and 8.3. The experiences with video consultation were positive, e.g. it did not cost patients effort (92%), they reported to have skills to use it (95%) and they intended to keep using it (95%). All nurses were satisfied with the quality of the sound, video and privacy and security. However, they recommended to use video consultation only in follow-up. CONCLUSIONS To our knowledge, this is the first Randomized Controlled Trial that examined the effects of video consultation on CPAP use over time for newly diagnosed OSA patients in combination with cognitive components and technology acceptance. The findings of this research suggest that, for patients starting CPAP, video consultation can preferably be used in combination with an initial face-to-face consultation and especially for patients with high levels of self-efficacy. Future research should focus on blended care approaches in which self-management and especially self-efficacy is receiving greater emphasis.

scholarly journals A Cross-Provider Health Care Management Program for Musculoskeletal Disorders: Results of a Randomized Controlled Trial in 22 German Companies

2021 ◽  
Vol 18 (22) ◽  
pp. 11844
Author(s):  
Kyung-Eun (Anna) Choi ◽  
Lara Lindert ◽  
Lara Schlomann ◽  
Christina Samel ◽  
Martin Hellmich ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Case Management ◽  
Sick Leave ◽  
Musculoskeletal Disorders ◽  
Self Efficacy ◽  
Controlled Trial ◽  
Self Management ◽  
Randomized Controlled ◽  
Management Group

Musculoskeletal disorders (MSDs) are among the most common cause for reduced work capacity and sick leave. Workplace health promotion programs are often neither tailored to the workplace nor the individual needs of the employees. To counteract lacking intersectional care, this four-year randomized controlled trial (RCT) aimed to investigate the effects of modular coordinating case management (treatment group) compared to supported self-management (control group) on MSD specific sick leave days (routine data), workability (WAI), self-efficacy (self-efficacy scale), and pain (German pain questionnaire, GPQ). The study network comprised 22 companies, 15 company health insurance funds, and 12 pension funds in Germany. Overall, 852 participants (Module A/early intervention: n = 651, Module B/rehabilitation: n = 190, Module C/reintegration: n = 10) participated. Both groups achieved fewer sick leave days, higher workability, and less pain (p < 0.0001) at follow-up compared to baseline. At follow-up, the coordinating case management group showed fewer disability days (GPQ), lower disability scores (GPQ), and lower pain intensities (GPQ) than the supported self-management group (p < 0.05), but no superiority regarding MSD specific sick leave days, workability, nor self-efficacy. Module A showed more comprehensive differences. The accompanying process evaluation shows barriers and facilitators for the implementation of the program, especially in a RCT setting.

scholarly journals Efficacy of a Web-Based Self-Management Enhancing Program for Patients with Rheumatoid Arthritis: Explorative Randomized Controlled Trial (Preprint)

2018 ◽  
Author(s):  
Rixt Zuidema ◽  
Sandra van Dulmen ◽  
Maria Nijhuis-van der Sanden ◽  
Inger Meek ◽  
Cornelia van den Ende ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Randomized Controlled Trial ◽  
Outcome Measures ◽  
Self Efficacy ◽  
Controlled Trial ◽  
Intervention Group ◽  
Self Management ◽  
Web Based ◽  
Positive Effects ◽  
Randomized Controlled

BACKGROUND Web-based self-management enhancing programs have the potential to support patients with rheumatoid arthritis (RA) in their self-management; for example, improve their health status by increasing their self-efficacy or taking their prescribed medication. We developed a Web-based self-management enhancing program in collaboration with RA patients and professionals as co-designers on the basis of the intervention mapping framework. Although self-management programs are complex interventions, it is informative to perform an explorative randomized controlled trial (RCT) before embarking on a larger trial. OBJECTIVE This study aimed to evaluate the efficacy of a Web-based self-management enhancing program for patients with RA and identify outcome measures most likely to capture potential benefits. METHODS A multicenter exploratory RCT was performed with an intervention group and a control group. Both groups received care as usual. In addition, the intervention group received 12 months of access to a Web-based self-management program. Assessment occurred at baseline, 6 months, and 12 months. Outcome measures included self-management behavior (Patient Activation Measurement, Self-Management Ability Scale), self-efficacy (Rheumatoid Arthritis task-specific Self-Efficacy, Perceived Efficacy in Patient-Physician Interaction), general health status (RAND-36), focus on fatigue (Modified Pain Coping Inventory for Fatigue), and perceived pain and fatigue (Numeric Rating Scales). A linear mixed model for repeated measures, using the intention-to-treat principle, was applied to study differences between the patients in the intervention (n=78) and control (n=79) groups. A sensitivity analysis was performed in the intervention group to study the influence of patients with high (N=30) and low (N=40) use of the intervention. RESULTS No positive effects were found regarding the outcome measurements. Effect sizes were low. CONCLUSIONS Based on these results, it is not possible to conclude on the positive effects of the intervention or to select outcome measures to be regarded as the primary/main or secondary outcomes for a future trial. A process evaluation should be performed to provide more insight into the low compliance with and effectiveness of the intervention. This can determine for whom this sort of program will work and help to fine-tune the inclusion criteria. CLINICALTRIAL Netherlands Trial Register NTR4871; https://www.trialregister.nl/trial/4726

scholarly journals Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trial

2017 ◽  
Vol 177 (1) ◽  
pp. 59-72 ◽  
Author(s):  
Cornelie D Andela ◽  
Han Repping-Wuts ◽  
Nike M M L Stikkelbroeck ◽  
Mathilde C Pronk ◽  
Jitske Tiemensma ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Self Efficacy ◽  
Illness Perceptions ◽  
Social Issues ◽  
Controlled Trial ◽  
Self Management ◽  
Future Research ◽  
Control Group ◽  
Randomized Controlled ◽  
Pituitary Disease

ContextPatients with pituitary disease report impairments in Quality of Life (QoL) despite optimal biomedical care. Until now, the effects of a self-management intervention (SMI) addressing psychological and social issues for these patients and their partners have not been studied.ObjectiveTo examine the effects of a SMI i.e. Patient and Partner Education Programme for Pituitary disease (PPEP-Pituitary).Design and subjectsA multicentre randomized controlled trial included 174 patients with pituitary disease, and 63 partners were allocated to either PPEP-Pituitary or a control group. PPEP-Pituitary included eight weekly sessions (90 min). Self-efficacy, bother and needs for support, illness perceptions, coping and QoL were assessed before the intervention (T0), directly after (T1) and after six months (T2). Mood was assessed before and after each session.ResultsPatients in PPEP-Pituitary reported improved mood after each session (except for session 1). In partners, mood only improved after the last three sessions. Patients reported higher self-efficacy at T1 (P = 0.016) which persisted up to T2 (P = 0.033), and less bother by mood problems directly after PPEP-Pituitary (P = 0.01), but more bother after six months (P = 0.001), although this increase was not different from baseline (P = 0.346). Partners in PPEP-Pituitary reported more vitality (P = 0.008) which persisted up to T2 (P = 0.034). At T2, partners also reported less anxiety and depressive symptoms (P ≤ 0.014).ConclusionThis first study evaluating the effects of a SMI targeting psychosocial issues in patients with pituitary disease and their partners demonstrated promising positive results. Future research should focus on the refinement and implementation of this SMI into clinical practice.

scholarly journals A pilot randomized controlled trial of a self-management group intervention for people with early-stage dementia (The SMART study)

2015 ◽  
Vol 28 (5) ◽  
pp. 787-800 ◽  
Author(s):  
Catherine Quinn ◽  
Gill Toms ◽  
Carys Jones ◽  
Andrew Brand ◽  
Rhiannon Tudor Edwards ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Self Efficacy ◽  
Group Intervention ◽  
Early Stage ◽  
Controlled Trial ◽  
Self Management ◽  
Randomized Controlled ◽  
Management Group ◽  
People With Dementia ◽  
Pilot Randomized Controlled Trial

ABSTRACTBackground:Self-management equips people to manage the symptoms and lifestyle changes that occur in long-term health conditions; however, there is limited evidence about its effectiveness for people with early-stage dementia. This pilot randomized controlled trial (RCT) explored the feasibility of a self-management intervention for people with early-stage dementia.Methods:The participants were people with early-stage dementia (n= 24) and for each participant a caregiver also took part. Participants were randomly allocated to either an eight-week self-management group intervention or treatment as usual (TAU). Assessments were conducted at baseline, three months and six months post-randomization by a researcher blind to group allocation. The primary outcome measure was self-efficacy score at three months.Results:Thirteen people with dementia were randomized to the intervention and 11 to TAU. Two groups were run, the first consisting of six people with dementia and the second of seven people with dementia. There was a small positive effect on self-efficacy with the intervention group showing gains in self-efficacy compared to the TAU group at three months (d =0.35), and this was maintained at six months (d =0.23). In terms of intervention acceptability, attrition was minimal, adherence was good, and satisfaction ratings were high. Feedback from participants was analyzed with content analysis. The findings suggest the positive aspects of the intervention were that it fostered independence and reciprocity, promoted social support, offered information, and provided clinician support.Conclusions:This study has provided preliminary evidence that self-management may be beneficial for people with early-stage dementia.

Sign in / Sign up

Export Citation Format

Share Document